New drug shows promise against ovarian and breast cancer
An international consortium of researchers has shown that an investigational drug, Olaparib, can reduce the size of tumors in women with advanced hereditary ovarian cancer with BRCA gene mutations.
Read Original Story
Categories: News, Science and Technology